Saji, H., Okada, M., Tsuboi, M., Nakajima, R., Suzuki, K., Aokage, K., . . . Asamura, H. (2022). Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. The Lancet (British edition), 399(10335), 1607-1617. https://doi.org/10.1016/S0140-6736(21)02333-3
Chicago-Zitierstil (17. Ausg.)Saji, Hisashi, et al. "Segmentectomy Versus Lobectomy in Small-sized Peripheral Non-small-cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Open-label, Phase 3, Randomised, Controlled, Non-inferiority Trial." The Lancet (British Edition) 399, no. 10335 (2022): 1607-1617. https://doi.org/10.1016/S0140-6736(21)02333-3.
MLA-Zitierstil (9. Ausg.)Saji, Hisashi, et al. "Segmentectomy Versus Lobectomy in Small-sized Peripheral Non-small-cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Open-label, Phase 3, Randomised, Controlled, Non-inferiority Trial." The Lancet (British Edition), vol. 399, no. 10335, 2022, pp. 1607-1617, https://doi.org/10.1016/S0140-6736(21)02333-3.